Patients with substance-use disorders in general and with opiate use in particular may suffer from different eating problems. A higher prevalence of eating disorders is evident in patients with opiate-use disorders than general population.
Three groups aged 20 to 50 years with 30 male participants in each group were included in the study. Participants in group 1 were opioid-dependent patients with <1 week’s abstinence from substance. Group 2 included patients with opioid dependence after completion of 30 days' detoxification. Participants in the third group consisted of volunteers with no substance-use disorders. Members of patient groups (1 and 2) were diagnosed according to DSM-IV and were tested using Addiction Severity Index, while the all 3 groups were tested using Eating Attitudes Test-26 (EAT-26).
Group 2 had the highest dieting scale score of EAT-36, followed by group 1 and group 3 (P=0.000). There was no difference with regard to bulimia and the Food Preoccupation Scale score in the 3 groups studied (P=0.123). Group 1 had the highest Oral control scale score followed by group 2 and group 3 (P=0.000). In the total EAT-36 score, patients with current opioid dependence had the highest scores (P=0.000). Tramadol daily dose correlated positively with the bulimia scale, oral control scale, and total EAT-26 in all patients of groups 1 and 2 together (P=0.014, 0.025, and 0.000, respectively).
Eating patterns among patients with opioid dependence are different from that of patients in recovery and the normal population.
Faculty of Medicine, Cairo University, Giza, Egypt
The authors declare no conflict of interest.
Reprints: Mohamed A. Khalil, MBBCH, MSc, MD, 8 Mohi El-Deen Abo El-Ezz Street, Dokki, Giza, Egypt 12311 (e-mails: firstname.lastname@example.org, email@example.com).